Sunday, September 13, 2026

Uncovering the Truth: The Controversial 8 Million USD North Korea Fund Transfer Explained

The People Power Party criticizes the Democratic Party's claims regarding North Korean remittances linked to Governor Lee Jae Myung as misinformation.

Is South Korea Preparing to Send Troops to the Hormuz Strait? Latest Updates from Defense Minister Ahn Gyu-back

Defense Minister Ahn Gyu-back clarifies no official U.S. military support requests have been received regarding the Strait of Hormuz.

BTS V’s Impact: How JINRO’s Global Campaign Surpassed 500 Million Views

Hite Jinro's global campaign with BTS's V surpasses 500 million views just two months after its launch.

Tag: Growth

Handok Positions Sleep Care as New Growth Driver, Linking Diagnosis, Treatment and Management

Handok is positioning sleep as a new digital health care growth driver by connecting diagnosis, treatment and everyday management through technologies such as digital therapeutics and AI-based sleep monitoring.

Celtrion’s Steqeyma Seizes 16% Market Share in the U.S.: What’s Next for This Autoimmune Treatment?

Celltrion's autoimmune drug Steqeyma surpasses 16% market share in the U.S., accelerating prescription growth and expansion.

“Second-Half Performance to Outpace First Half”… Celltrion Expected to Exceed Full-Year Revenue Target

Celltrion is expected to outperform its first-half results in the second half, driven by new-product growth, European tender wins and stronger demand for high-margin products, potentially allowing it to exceed its full-year targets.

K-Beauty Revolution: How Korean Medical Aesthetic Devices Are Dominating Global Markets

South Korea's skin beauty medical device companies are continuing to grow, focusing on the overseas market.

SK Biopharmaceuticals Introduces Opacalim: Aiming for a 2029 U.S. Launch of an Innovative Epilepsy Treatment

Opacalim licensing marks not an end, but a new beginning for opportunities and growth in the industry.

Cognitive Training Revolution: Emocog’s Cogthera Surpasses 2000 Prescriptions in Just 12 Weeks

Emocog's digital therapy device Cogthera surpasses 2,000 prescriptions, indicating its successful integration into healthcare for elderly patients.

HLB Panagene Posts Operating Profit in First Half, Accelerates PNA Business Expansion

HLB Panagene remained profitable in the first half as it expands its PNA business and accelerates development of antibody-oligonucleotide conjugates.

Unlocking Growth: How Biopharmaceuticals’ Cenobamate is Transforming Epilepsy Treatment in Asia

SK Biopharmaceuticals' epilepsy drug Cenobamate is expected to continue its growth trend in the second half of the year.

July 2026 Sales Surge: Hyundai and Kia’s Record-Breaking 165,000 Vehicle Sales in the U.S.

Hyundai and Kia achieved record July sales in the U.S., reaching over 165,000 units, a 5% increase from last year, driven by HEV sales.

Celltrion accelerates mechanism diversification strategy, expands autoimmune disease portfolio

Celltrion accelerates the development of biosimilars for autoimmune disease treatments, expanding its portfolio for long-term growth.

Celltrion expands U.S. PBM coverage, boosting outlook for high-margin biosimilars

Celltrion expands its listing with US PBM, enhancing its high-profit biosimilar product base and boosting sales expectations for H2.

LG CNS Reports 4.2% Revenue Growth in AI Sector: What This Means for Investors

LG CNS continues to grow in revenue thanks to AI, but profitability has decreased due to expanded investments in the sector.

Samsung SDS Q2 Revenue Rises 5.9% YoY to $2.48 Billion

Samsung SDS reports Q2 2026 revenue of $2.48 billion, a 5.9% increase, with operating profit rising 0.7% to $155 million.

Samsung Secures Major 2nm Semiconductor Orders: What This Means for AI and Future Tech

Samsung Electronics secures 2nm foundry orders, expecting a significant increase in demand from AI sector clients this year.

Top News

- Our Sponsors Ad -

Follow us